Clinical Trial Update: Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describes a Phase 1/2 study of a docetaxel, cisplatin, and 5-fluorouracil combination for unresectable advanced esophageal squamous cell c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: Wakayama Medical University | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: UNKNOWN